| Product Code: ETC6662004 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Neuropathic Pain Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Neuropathic Pain Market - Industry Life Cycle |
3.4 Canada Neuropathic Pain Market - Porter's Five Forces |
3.5 Canada Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Canada Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 Canada Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 Canada Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 Canada Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 Canada Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 Canada Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neuropathic pain in Canada |
4.2.2 Growing awareness and diagnosis of neuropathic pain conditions |
4.2.3 Advancements in healthcare technology and treatment options for neuropathic pain patients |
4.3 Market Restraints |
4.3.1 High cost of neuropathic pain treatments and medications |
4.3.2 Limited reimbursement options for neuropathic pain management |
4.3.3 Regulatory challenges and approval processes for new neuropathic pain therapies |
5 Canada Neuropathic Pain Market Trends |
6 Canada Neuropathic Pain Market, By Types |
6.1 Canada Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Canada Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 Canada Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 Canada Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 Canada Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Canada Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 Canada Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 Canada Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 Canada Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Canada Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 Canada Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 Canada Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 Canada Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 Canada Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 Canada Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 Canada Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 Canada Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 Canada Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 Canada Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 Canada Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 Canada Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 Canada Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 Canada Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 Canada Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 Canada Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 Canada Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 Canada Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 Canada Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 Canada Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 Canada Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 Canada Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Canada Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 Canada Neuropathic Pain Market Import-Export Trade Statistics |
7.1 Canada Neuropathic Pain Market Export to Major Countries |
7.2 Canada Neuropathic Pain Market Imports from Major Countries |
8 Canada Neuropathic Pain Market Key Performance Indicators |
8.1 Patient satisfaction scores with neuropathic pain treatments |
8.2 Number of healthcare professionals specializing in neuropathic pain management |
8.3 Adoption rate of innovative neuropathic pain treatment technologies |
8.4 Percentage of patients achieving pain relief and improved quality of life |
8.5 Rate of new neuropathic pain treatment approvals and market penetrations |
9 Canada Neuropathic Pain Market - Opportunity Assessment |
9.1 Canada Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Canada Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 Canada Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 Canada Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 Canada Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 Canada Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 Canada Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Canada Neuropathic Pain Market - Competitive Landscape |
10.1 Canada Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 Canada Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here